FindTrial
Sign In

Evaluating the Effect of Silver Nanoparticles Derived from Herbal Plant Arjuna as Photocatalyst in Photodynamic Therapy along with Scaling in Patients with Chronic Gum Disease.

Clinical Evaluation of Effectiveness of Silver Nanoparticles Derived from Terminalia Arjuna Plant Extract as Photocatalyst in Photodynamic Therapy as an Adjunct to Scaling and Root Planing in the Management of Chronic Periodontitis A Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080624
Enrollment
40
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Silver Nanoparticles as Photocatalyst in Photodynamic therapy: Silver Nanoparticles Derived from Terminalia Arjuna Plant Extract as Photocatalyst in Photodynamic therapy. The Total Dura

Sponsors

Dr. Priyanka Dalvi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) systemically healthy adult 25-50 years age group. 2)periodontal pockets greater than 3mm and less than 5mm deep. 2) Patients with chronic periodontitis 3) Patient willing to give the informed consent and willing to comply with the study were selected

Exclusion criteria

Exclusion criteria: 1) Systemic diseases- active cancer, photodermatoses, photoallergies, encephalitis, meningitis, hyper/ hypo thyroidism. 2) Pregnancy. 3) Smoking

Design outcomes

Primary

MeasureTime frame
1. Plaque Index (P.I.) (Silness and Loe) 2. Gingival Index (G.I.) (Loe and Silness, 1963) 3. Probing Pocket Depth (PPD) 4. Clinical Attachment Level (CAL)Timepoint: 1) At Baseline 2) After 1 month 3) After 3 month—

Secondary

MeasureTime frame
1. Plaque Index (P.I.) (Silness and Loe) 2. Gingival Index (G.I.) (Loe and Silness, 1963) 3. Probing Pocket Depth (PPD) 4. Clinical Attachment Level (CAL)Timepoint: 1) At Baseline 2) After 1 month 3) After 3 month—

Countries

India

Contacts

Public ContactDr Mala Dixit Baburaj

Nair Hospital Dental College, Mumbai

maladixit25@gmail.com9223340938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026